Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0333 USD | -7.50% | -4.86% | -95.24% |
11/04 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
04/04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Sales 2021 | 2.21M 184M | Sales 2022 | 4.76M 397M | Capitalization | 25.39M 2.12B |
---|---|---|---|---|---|
Net income 2021 | -45M -3.76B | Net income 2022 | -26M -2.17B | EV / Sales 2021 | 31.5 x |
Net cash position 2021 | 20.53M 1.71B | Net cash position 2022 | 433K 36.14M | EV / Sales 2022 | 5.25 x |
P/E ratio 2021 |
-1.9
x | P/E ratio 2022 |
-0.96
x | Employees | 12 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.68% |
Latest transcript on DMK Pharmaceuticals Corporation
1 day | -7.50% | ||
1 week | -4.86% | ||
Current month | -35.96% | ||
1 month | -44.96% | ||
3 months | -93.83% | ||
6 months | -93.56% | ||
Current year | -95.24% |
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 25/23/25 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 16/23/16 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 26/19/26 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 25/23/25 |
Vickie Reed
BRD | Director/Board Member | 62 | 24/22/24 |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 0.0333 | -7.50% | 16,253 |
30/24/30 | 0.036 | +2.86% | 32,092 |
29/24/29 | 0.035 | 0.00% | 13,860 |
26/24/26 | 0.035 | -2.78% | 143,836 |
25/24/25 | 0.036 | -14.29% | 35,977 |
Delayed Quote OTC Markets, May 02, 2024 at 01:26 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-95.24% | 363K | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- DMKPQ Stock